HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral administration of mangiferin ameliorates diabetes in animal models: a meta-analysis and systematic review.

Abstract
Although mangiferin has a number of documented beneficial effects, there are no systematic reviews or meta-analyses of its effects in diabetic animal models. To investigate the effects of oral administration of mangiferin on blood glucose levels, body weight, and total cholesterol and triglycerides levels in diabetic animal models, a meta-analysis was conducted and the underlying mechanisms were reviewed. Studies from 6 databases (PubMed, Web of Science, Embase, Cochrane Library, and CNKI (China National Knowledge Infrastructure), and Wanfang Med) were searched from inception to April 2020. After article screening, a total of 19 articles were included in this meta-analysis. The meta-analysis was performed using RevMan 5.3 and STATA 14.0 software. The overall pooled estimate of standardized mean difference (SMD) of mangiferin's effect on blood glucose was -1.27 (95% confidence interval [CI]: -1.71, -0.82, P < .00001). Body weight increased in lean diabetic animals with an SMD of 1.41 (95% CI: 0.57, 2.25; P = .001), while it decreased in obese diabetic animals with an SMD of -0.92 (95% CI: -1.69, -0.14; P = .02). Mangiferin intake reduced serum total cholesterol and triglycerides levels with SMDs of -1.02 (95% CI: -1.43, -0.61; P < .001) and -1.24 (95% CI: -1.70, -0.79; P < .001), respectively. The meta-analysis suggests that oral intake of mangiferin has a significant antidiabetic effect in animal models, and the systematic review suggested that this function might be attributed to its anti-inflammatory and antioxidative properties, as well as to its function of improving glycolipid metabolism and enhancing insulin signaling.
AuthorsYou Wu, Wei Liu, Tao Yang, Mei Li, Lingling Qin, Lili Wu, Tonghua Liu
JournalNutrition research (New York, N.Y.) (Nutr Res) Vol. 87 Pg. 57-69 (03 2021) ISSN: 1879-0739 [Electronic] United States
PMID33601215 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review)
CopyrightCopyright © 2020. Published by Elsevier Inc.
Chemical References
  • Blood Glucose
  • Hypoglycemic Agents
  • Triglycerides
  • Xanthones
  • mangiferin
  • Cholesterol
Topics
  • Animals
  • Blood Glucose (analysis)
  • Body Weight
  • Cholesterol (blood)
  • Diabetes Mellitus (diet therapy)
  • Diabetes Mellitus, Experimental (diet therapy)
  • Diabetes Mellitus, Type 2 (diet therapy)
  • Diet, High-Fat
  • Dietary Supplements
  • Female
  • Hypoglycemic Agents (administration & dosage)
  • Male
  • Obesity
  • Triglycerides (blood)
  • Xanthones (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: